2020-03-30FDA approves durvalumab for extensive-stage small cell lung cancerTrial CASPIANDrugs IMFINZI (durvalumab) · Anti-PD-L1 antibody, etoposide · Topoisomerase II inhibitorConditionThoracic
2019-03-18FDA approves atezolizumab for extensive-stage small cell lung cancerTrial IMpower133Drugs TECENTRIQ (atezolizumab) · Anti-PD-L1 antibody, carboplatin · Platinum agent, etoposide · Topoisomerase II inhibitorConditionThoracic